Duobing B. Zou
Ningbo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
EWSR1 as a candidate prognostic indicator in acute myeloid leukemia.
Journal: Hematology (Amsterdam, Netherlands)
Published: November 24, 2025
Integrating global burden of disease analysis and single-cell omics identifies ANTXR2 as a potential diagnostic biomarker for AML in China.
Journal: International immunopharmacology
Published: November 04, 2025
Fucoxanthin inhibits the proliferation of MOLM13 cells by targeting AKT to disrupt glucose metabolism.
Journal: Frontiers in pharmacology
Published: March 27, 2025
Prognostic significance red blood cell distribution width in myelodysplastic syndromes
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: January 28, 2023
Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome.
Journal: Frontiers in nutrition
Published: December 16, 2022
Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone.
Journal: Annals of hematology
Published: December 06, 2022
MLL-SEPT5 Fusion Transcript in Myelodysplastic Syndrome Patient With t(11;22)(q23;q11).
Journal: Frontiers in medicine
Published: September 25, 2021
Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis.
Journal: The Journal of international medical research
Published: December 13, 2019
Diagnostic dilemma in AML with MDS-related changes and blasts of mixed lineage: A case report.
Journal: Leukemia research
Published: April 09, 2019
Last Updated: 09/26/2026